About GH Research
GH Research is a company based in Dublin (Ireland) founded in 2018 by Magnus C Halle and Theis Terwey.. GH Research has raised $125 million across 1 funding round from investors including Citadel, RTW Investments and RA Capital. The company has 50 employees as of December 31, 2024. GH Research offers products and services including GH001 and GH002. GH Research operates in a competitive market with competitors including Lykos, Small Pharma and Ketabon, among others.
- Headquarter Dublin, Ireland
- Employees 50 as on 31 Dec, 2024
- Founders Magnus C Halle, Theis Terwey
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Gh Research Plc
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-38.96 M-9.48as on Dec 31, 2024
-
EBITDA
$-49.93 M-22.06as on Dec 31, 2024
-
Total Equity Funding
$125 M (USD)
in 1 rounds
-
Latest Funding Round
$125 M (USD), Series B
Apr 12, 2021
-
Investors
Citadel
& 10 more
-
Employee Count
50
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of GH Research
GH Research is a publicly listed company on the NASDAQ with ticker symbol GHRS in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of GH Research
GH Research offers a comprehensive portfolio of products and services, including GH001 and GH002. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Pulmonary inhalation therapy for depression treatment
Intravenous administration for neurological disorders
Unlock access to complete
Unlock access to complete
Scientific Team
7 people
Finance and Accounting
3 people
Co Team
2 people
Accounts Team
1 people
Leadership Team
1 people
Unlock access to complete
Funding Insights of GH Research
GH Research has successfully raised a total of $125M through 1 strategic funding round. The most recent funding activity was a Series B round of $125 million completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $125.0M
-
First Round
First Round
(12 Apr 2021)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2021 | Amount | Series B - GH Research | Valuation | RA Capital Management , RTW Investments |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in GH Research
GH Research has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include Citadel, RTW Investments and RA Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life Sciences focused VC firm investing in the US
|
Founded Year | Domain | Location | |
|
US private equity investments are managed by BVF Partners.
|
Founded Year | Domain | Location | |
|
Biotech startups are funded by this venture capital firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GH Research
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - GH Research
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Gh Research Comparisons
Competitors of GH Research
GH Research operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lykos, Small Pharma and Ketabon, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of therapeutics to treat mental health conditions
|
|
| domain | founded_year | HQ Location |
Psychedelic-based therapeutics for mental health conditions are developed.
|
|
| domain | founded_year | HQ Location |
Develops innovative therapeutics for treatment-resistant depression.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Gh Research
Frequently Asked Questions about GH Research
When was GH Research founded?
GH Research was founded in 2018 and raised its 1st funding round 3 years after it was founded.
Where is GH Research located?
GH Research is headquartered in Dublin, Ireland.
Who is the current CEO of GH Research?
Theis Terwey is the current CEO of GH Research. They have also founded this company.
Is GH Research a funded company?
GH Research is a funded company, having raised a total of $125M across 1 funding round to date. The company's 1st funding round was a Series B of $125M, raised on Apr 12, 2021.
How many employees does GH Research have?
As of Dec 31, 2024, the latest employee count at GH Research is 50.
What does GH Research do?
GH Research was founded in 2018 and is based in Dublin, Ireland. Focus is placed on the biotechnology sector, where treatments for mental disorders are developed. The pipeline includes GH001, an inhalable 5-MeO-DMT product intended for resistant depression and related conditions, and GH002, an injectable 5-MeO-DMT formulation for mental health applications. Operations center on advancing these candidates through clinical stages.
Who are the top competitors of GH Research?
GH Research's top competitors include Lykos, Small Pharma and Ketabon.
What products or services does GH Research offer?
GH Research offers GH001 and GH002.
Is GH Research publicly traded?
Yes, GH Research is publicly traded on NASDAQ under the ticker symbol GHRS.
Who are GH Research's investors?
GH Research has 11 investors. Key investors include Citadel, RTW Investments, RA Capital, Verition Fund Management, and BVF Partners.
What is GH Research's ticker symbol?
The ticker symbol of GH Research is GHRS on NASDAQ.